Sleep problems and their effects on people with Ménière's disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational investigation of adults treated for Ménière's disease in the ENT department at Strasbourg University Hospital between June 1, 2019 and January 31, 2021. Researchers will review clinical records and available sleep-related data to look for relationships between vertigo severity and measures of sleep disturbance. Patients with prior intracranial surgery or degenerative neurological disease were excluded, and those with prior sleep medicine consultations were not included. The work responds to limited prior evidence and to French otolaryngology guidance that recommends attention to sleep in Ménière's disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult (≥18 years)
* Patient followed for Ménière's disease in the ENT department at Strasbourg University Hospital between June 1, 2019, and January 31, 2021.

Exclusion Criteria:

* History of intracranial surgery or degenerative neurological disease.
* No prior sleep medicine consultations.

Where it's running

• Service d'ORL et de Chirurgie Cervico-faciale - Hôpitaux Universitaires de Strasbourg
  Strasbourg, France Recruiting

Study contacts

• Study coordinator: Anne CHARPIOT, MD, PhD
• Email: anne.charpiot@chru-strasbourg.fr
• Phone: 33 3 88 12 76 41

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Berobenatide in adults with sleep apnea and obesity who don’t use a PAP machine

  This study tests berobenatide versus placebo in adults with moderate-to-severe obstructive sleep apnea and overweight or obesity who are not using PAP therapy.

  Recruiting at 3 sites Phase 3 Pfizer · Cullman, Alabama and 3 other locations · NCT07881757

• Berobenatide in adults with sleep apnea and obesity using a PAP machine

  This study tests berobenatide vs. placebo in adults with moderate to severe obstructive sleep apnea and overweight/obesity who use a PAP device.

  Recruiting at 6 sites Phase 3 Pfizer · Cullman, Alabama and 7 other locations · NCT07823608

• Diaphragmatic Breathing to Improve Sleep in Women with PCOS

  This study tests whether diaphragmatic breathing exercises can improve sleep quality for women with PCOS who have sleep problems.

  Recruiting Cairo University · Cairo, Cairo Governorate · NCT07698925

• CBT-I with Melatonin for Older Adults with Chronic Insomnia

  In people aged 60 and over with chronic insomnia, researchers will test whether CBT-I plus nightly melatonin helps sleep better than CBT-I with a placebo or sleep-health education with placebo.

  Recruiting The University of Hong Kong · Hong Kong · NCT07695246

• Sleep problems, fatigue, and thinking ability in people with MS

  We will try to see if sleep problems explain why adults with MS feel very tired and have trouble thinking.

  Recruiting at 2 sites Heinrich-Heine University, Duesseldorf · Düsseldorf and 1 other locations · NCT07426991

• Screening for sleep disorders in children with cerebral palsy using connected tools

  This study is testing a new way to use connected tools to find sleep problems in children with cerebral palsy, so they can get the help they need.

  Recruiting University Hospital, Brest · Angers and 5 other locations · NCT03915418

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.